Yu-Zhen Ye | Genetics | Best Researcher Award

Posted on by ScienceFather

Ms. Yu-Zhen Ye | Genetics | Best Researcher Award

PhD at National Taiwan University, Taiwan

Yu-Zhen Ye is a distinguished researcher in immunology, currently pursuing a Ph.D. at National Taiwan University. His research focuses on macrophage differentiation and metabolic processes, with significant contributions to understanding immune responses in disease contexts. Notable achievements include receiving the High Distinction Award (2024), Best Poster Award (2023), and Outstanding Work Award (2022). Yu-Zhen has published impactful articles and conference papers on macrophage polarization and cancer cell mechanisms. His presentations at major conferences and active memberships in professional societies such as the American Association of Immunologists highlight his commitment to advancing the field. His work on Serum Amyloid A3 and its roles in immune modulation and cancer treatment reflects a high level of expertise and innovation. Although expanding his research impact and securing additional funding could further enhance his career, Yu-Zhen’s accomplishments make him a strong contender for the Research for Best Researcher Award.

Profile:

Education

Yu-Zhen Ye’s educational journey reflects a robust foundation in biomedical sciences and a commitment to advancing research in immunology. He began his academic pursuit with a Bachelor of Science in Biomedical Sciences from Chung Shan Medical University (CSMU) in Taichung, Taiwan, where he graduated in June 2022. During his undergraduate studies, Yu-Zhen investigated the molecular mechanisms underlying the inhibition of endometrial cancer cell proliferation by Ovatodiolide. Building on this strong foundation, he pursued a Ph.D. in Biochemical Science and Technology at National Taiwan University (NTU) in Taipei, Taiwan, starting in September 2022. His doctoral research focuses on macrophage differentiation and polarization, aiming to elucidate the mechanisms of immune cell function in type 1 and type 2 immunity activation models. This educational background underscores his dedication to exploring and advancing knowledge in immunology.

Professional Experience

Yu-Zhen Ye is currently pursuing a Ph.D. in the Department of Biochemical Science & Technology at National Taiwan University (NTU) in Taipei, Taiwan, since September 2022. His research centers on the mechanisms of macrophage differentiation and polarization in type 1 and type 2 immunity activation models, aiming to enhance understanding of immune responses in various disease contexts. Prior to his doctoral studies, Yu-Zhen earned his B.S. in Biomedical Sciences from Chung Shan Medical University (CSMU) in Taichung, Taiwan, where he investigated the molecular mechanisms by which Ovatodiolide inhibits endometrial cancer cell proliferation. His professional experience includes significant research contributions and presentations at various conferences, reflecting his expertise in immunology and his commitment to advancing knowledge in the field.

Research Interest

Yu-Zhen Ye’s research interests center on immunology, with a particular focus on macrophage biology. His work explores the differentiation of macrophages from monocyte-derived precursors to tissue-resident cells, emphasizing how these immune cells adapt and function within various tissues. Yu-Zhen investigates macrophage polarization, studying both classical and alternative activation pathways to understand how these cells contribute to type 1 and type 2 immune responses. His research also delves into the metabolic processes governing macrophage function and their role in disease contexts. By examining the molecular mechanisms underlying macrophage conversion and polarization, Yu-Zhen aims to enhance our understanding of immune responses and develop potential therapeutic strategies for diseases where macrophage function is disrupted, such as cancer and chronic inflammation. His work is pivotal in elucidating how key molecules influence immune cell behavior and contribute to disease progression and treatment.

Research Skills

Yu-Zhen Ye exhibits a robust set of research skills in the field of immunology, particularly focusing on macrophage differentiation and metabolic processes. His expertise encompasses the investigation of macrophage polarization through classical and alternative activation models, contributing to a deeper understanding of immune responses in type 1 and type 2 immunity contexts. Yu-Zhen demonstrates proficiency in conducting advanced research, as evidenced by his significant publications and conference presentations. His skills include meticulous experimental design, application of multi-omic analyses, and the ability to elucidate complex molecular mechanisms. Furthermore, his adeptness in presenting research findings at prominent conferences highlights his capability to communicate complex scientific concepts effectively. His research also reflects a strong ability to secure and utilize research grants, underscoring his competence in both experimental and grant-related aspects of academic research. Overall, Yu-Zhen Ye’s research skills are characterized by depth, precision, and effective dissemination of scientific knowledge.

Award and Recognition

Yu-Zhen Ye has garnered significant accolades for his pioneering research in immunology. His dedication to studying macrophage differentiation and polarization has been recognized with several prestigious awards. Notably, he received the High Distinction Award at the 38th Joint Annual Conference of Biomedical Science in 2024 and the Best Poster Award at the Multiomics and Precision Medicine Joint Conference in 2023. Additionally, he was honored with the Outstanding Work Award at the Annual Meeting of the Health Food Society of Taiwan in 2022. These awards reflect his exceptional contributions to understanding immune responses and cancer cell mechanisms. His impactful research, combined with his active participation in leading conferences and memberships in prominent professional societies, underscores his prominence and influence in the field of immunology. Yu-Zhen Ye’s achievements highlight his significant role in advancing scientific knowledge and his commitment to excellence in research.

Conclusion

Yu-Zhen Ye demonstrates exceptional research capabilities and achievements in immunology, with significant contributions to the understanding of macrophage function and cancer cell mechanisms. His awards, publications, and conference presentations underline his strong performance and recognition in his field. While there are areas for potential growth, particularly in expanding research impact and collaboration, Yu-Zhen’s accomplishments make him a strong candidate for the Research for Best Researcher Award. His continued focus on innovative research and professional engagement positions him well for further success and recognition in the scientific community.

 

Paul Cullen | Genetics | Best Researcher Award

Posted on by ScienceFather

Dr. Paul Cullen | Genetics | Best Researcher Award

Doctorate at University at Buffalo, United States

Dr. Paul Cullen is a Professor in the Department of Biological Sciences at the University at Buffalo, specializing in molecular genetics and cell biology. He completed his postdoctoral training at the Institute of Molecular Biology at the University of Oregon, where he worked on MAP kinase (MAPK) signaling pathways, funded by grants from the American Heart Association and the National Institutes of Health (NIH). Dr. Cullen earned his Ph.D. in Molecular Genetics from Washington University in Saint Louis, where his research focused on bacterial nitrogen control proteins. He holds a Bachelor of Science in Biological Sciences from the University of Illinois at Urbana-Champaign, graduating Magna Cum Laude with Distinction. Dr. Cullen’s research interests revolve around understanding the regulation of cellular differentiation and signaling pathways, particularly in yeast. He has received numerous accolades, including the UB Exceptional Scholar’s Award and the Distinguished Postdoc Mentor Award. His work is supported by multiple NIH grants, and he has contributed significantly to the scientific community through publications and mentorship.

Profile

Education

Dr. Paul Cullen holds an impressive educational background in the field of biological sciences and molecular genetics. He earned his Bachelor of Science degree in Biological Sciences from the University of Illinois, Urbana-Champaign, graduating Magna Cum Laude with Distinction in 1990. His undergraduate thesis, titled “Effect of Ecdysone on In Vitro Pupal Wing Development in Lepidoptera,” was conducted under the supervision of Dr. Judith Willis and Dr. Johnathan Widom. Following this, Dr. Cullen pursued his Doctor of Philosophy (Ph.D.) in Molecular Genetics at Washington University, Saint Louis, completing his degree in 1997. His Ph.D. research, titled “Bacterial Nitrogen Control Proteins,” was guided by Dr. Robert G. Kranz. Additionally, from 1998 to 2004, Dr. Cullen completed postdoctoral training at the Institute of Molecular Biology at the University of Oregon, under the mentorship of Dr. George F. Sprague, Jr. His postdoctoral work was supported by prestigious grants from the American Heart Association and the National Institutes of Health (NIH), further solidifying his expertise in molecular biology.

Professional Experience

Dr. Paul Cullen has held a series of prestigious academic and research positions throughout his career. He is currently a Professor in the Department of Biological Sciences at the University at Buffalo, where he has been a faculty member since 2004. Prior to his promotion to Professor in 2017, Dr. Cullen served as an Associate Professor from 2010 to 2017 and as an Assistant Professor from 2004 to 2010. He has also held a joint appointment as Clinical Research Assistant Professor in the Department of Microbiology and Immunology since 2005. Earlier in his career, Dr. Cullen was a Senior Research Fellow at the Institute of Molecular Biology at the University of Oregon from 2000 to 2004. He has also contributed to scientific review panels, including serving as an NIH Review Panelist for Eukaryotic Pathogens in 2024. In addition to his research, Dr. Cullen has been deeply involved in academic administration, serving as the Director of Graduate Affairs for the Department of Biological Sciences from 2019 to 2024 and as a member of the Graduate School Executive Committee from 2023 to 2024.

Research Interest

Dr. Paul Cullen’s research interests focus on understanding the molecular mechanisms that regulate cellular differentiation, particularly through MAP kinase (MAPK) signaling pathways. His work explores how these pathways control cellular responses to environmental cues, with a special emphasis on the filamentous growth of Saccharomyces cerevisiae (yeast). Dr. Cullen investigates the role of cell polarity proteins in modulating MAPK signaling and how regulatory proteins influence these pathways. His research also extends to studying signal transduction in various biological systems, aiming to uncover broader implications for cellular behavior and development in eukaryotic organisms. Through his work, Dr. Cullen seeks to advance knowledge of genetic and molecular processes that underpin complex biological responses, contributing to the fields of molecular genetics, cell biology, and microbiology.

Research Skills

Dr. Paul Cullen possesses extensive research skills in molecular genetics and cell biology, particularly in the regulation of MAP kinase (MAPK) signaling pathways. His expertise includes advanced molecular techniques such as gene manipulation, protein-protein interaction studies, and genetic screening in model organisms like Saccharomyces cerevisiae. Dr. Cullen is skilled in using molecular and genetic tools to investigate cellular differentiation, signal transduction, and environmental response mechanisms. He has a strong background in high-throughput screening, microscopy, and quantitative data analysis. His research also involves cutting-edge technologies in genetic sequencing, bioinformatics, and structural biology, contributing to his deep understanding of cellular signaling networks and their implications for health and disease.

Award and Recognition

Dr. Paul Cullen has received numerous accolades for his exemplary contributions to research and education. In 2023, he was honored with the UB Exceptional Scholar’s Award for Sustained Achievement and the UB Graduate School Distinguished Postdoc Mentor Award, recognizing his significant impact in mentorship. Additionally, he received the Milton Plesur Excellence in Teaching Award in 2008 for his dedication to student learning. His active membership in professional organizations such as the American Society of Cell Biology and the American Society of Microbiology further highlights his commitment to advancing the field of molecular biology.

Conclusion

Dr. Paul Cullen’s remarkable achievements in molecular biology, sustained research contributions, and commitment to mentoring make him a distinguished figure in his field. His combination of academic excellence, leadership, and impactful research positions him as an exemplary candidate for the “Research for Best Researcher Award.”

Publication Top Notes

  • “Glucose depletion causes haploid invasive growth in yeast”
    • Journal: Proceedings of the National Academy of Sciences
    • Cited by: 444
    • Year: 2000
    • Volume: 97, Issue 25
    • Pages: 13619-13624
  • “The regulation of filamentous growth in yeast”
    • Journal: Genetics
    • Cited by: 348
    • Year: 2012
    • Volume: 190, Issue 1
    • Pages: 23-49
  • “A signaling mucin at the head of the Cdc42-and MAPK-dependent filamentous growth pathway in yeast”
    • Journal: Genes & Development
    • Cited by: 268
    • Year: 2004
    • Volume: 18, Issue 14
    • Pages: 1695-1708
  • “GTPase-activating proteins for Cdc42”
    • Journal: Eukaryotic Cell
    • Cited by: 170
    • Year: 2002
    • Volume: 1, Issue 3
    • Pages: 469-480
  • “Defects in Protein Glycosylation Cause SHO1-Dependent Activation of a STE12 Signaling Pathway in Yeast”
    • Journal: Genetics
    • Cited by: 147
    • Year: 2000
    • Volume: 155, Issue 3
    • Pages: 1005-1018
  • “Cleavage of the signaling mucin Msb2 by the aspartyl protease Yps1 is required for MAPK activation in yeast”
    • Journal: The Journal of Cell Biology
    • Cited by: 144
    • Year: 2008
    • Volume: 181, Issue 7
    • Pages: 1073-1081
  • “Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis”
    • Journal: PLoS One
    • Cited by: 112
    • Year: 2012
    • Volume: 7, Issue 11
    • Pages: e46020
  • “Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins”
    • Journal: NPJ Biofilms and Microbiomes
    • Cited by: 111
    • Year: 2019
    • Volume: 5, Issue 1
    • Pages: 21

Hayati Türkmen | Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Hayati Türkmen | Genetics and Molecular Biology | Best Researcher Award 

Turkiye of Ege University, Turkey.

Prof. Dr. Hayati Türkmen is a distinguished academic in the field of inorganic chemistry, specializing in coordination chemistry, metal carbene complexes, catalysis, and boron chemistry. With a solid educational background, including a Ph.D. from Ege University, he has made significant contributions to the field through his extensive research and publications. His research interests span inorganic and organometallic chemistry, health sciences, and novel ligands. Dr. Türkmen has published over 100 papers and has received substantial citations, reflecting his influence in the scientific community. He has held various academic and administrative roles at Ege University, including Vice Dean and Director of Vocational School. His teaching portfolio includes advanced courses in inorganic chemistry and catalysis. Dr. Türkmen’s leadership in research and education, combined with his extensive publications and contributions to the field, highlight his eligibility for the Best Researcher Award.

Profile
Education

Dr. Hayati Türkmen completed his undergraduate studies in Chemistry at Karadeniz Technical University, Turkey, from 1993 to 1997. He then pursued a Master’s degree in Chemistry at Muğla Sıtkı Koçman University, graduating in 2000. Dr. Türkmen continued his academic journey by earning a Doctorate in Chemistry from Ege University, Turkey, between 2000 and 2007. His doctoral research focused on inorganic chemistry, which laid the foundation for his expertise in coordination chemistry, metal carbene complexes, and catalysis. This comprehensive educational background has equipped Dr. Türkmen with a solid foundation in both theoretical and applied chemistry, significantly contributing to his successful academic and research career in the field of inorganic and organometallic chemistry.

Professional Experience

Prof. Dr. Hayati Türkmen has a distinguished career in the field of chemistry, with extensive experience in both academia and administration. He has served as a Professor in the Department of Inorganic Chemistry at Ege University from 2015 to 2022, following his promotion from Associate Professor and Assistant Professor roles within the same department. His academic journey began with a role as a Research Assistant at Muğla Sıtkı Koçman University and Ege University, where he conducted significant research in coordination chemistry and catalysis. Prof. Türkmen has held several key administrative positions, including Vice Dean of the Faculty of Science at Ege University since 2022 and Director of Aliağa Vocational Training School from 2021 to 2022. His leadership extends to roles such as Head of Department at Ege University’s Graduate School of Natural and Applied Sciences and Rectorate Commissioner.

Research Interest

Dr. Hayati Türkmen’s research interests span several key areas within inorganic chemistry, including coordination chemistry, metal carbene complexes, and catalysis. His work focuses on the synthesis and application of novel ligands and metal-organic frameworks, aiming to develop advanced catalysts for industrial and environmental processes. Dr. Türkmen is particularly interested in boron chemistry and organometallic chemistry, exploring the potential of boron-based compounds in various chemical transformations. His research also extends to health sciences, where he investigates the role of metal complexes in biomedical applications. By integrating these diverse fields, Dr. Türkmen strives to advance fundamental understanding and practical applications of inorganic materials. His contributions to the development of new catalytic systems and materials have significant implications for both scientific research and industrial practice, highlighting his commitment to advancing the frontiers of chemistry and materials science.

Research Skills

Prof. Dr. Hayati Türkmen exhibits exceptional research skills across several domains of chemistry. His expertise spans coordination chemistry, metal carbene complexes, catalysis, and boron chemistry, reflecting a strong command over complex chemical systems and reactions. Dr. Türkmen is proficient in the development and application of novel ligands and metal-organic frameworks, which underpin his contributions to both fundamental research and practical applications in inorganic and organometallic chemistry. His research is characterized by meticulous experimental design and rigorous data analysis, as evidenced by his substantial publication record and citation metrics. Dr. Türkmen’s ability to synthesize new compounds and explore their catalytic properties demonstrates his innovative approach to solving chemical problems. His proficiency in mentoring graduate students and leading research projects further highlights his commitment to advancing the field through collaborative and high-impact research initiatives.

 Awards and Recognition

Dr. Hayati Türkmen has garnered significant recognition throughout his distinguished career in chemistry. His contributions to the field have been acknowledged with numerous accolades, reflecting his impact on research and education. Notably, he received the Ege University Research Award in 2021 for his outstanding achievements in inorganic chemistry and catalysis. In 2018, he was honored with the Excellence in Research Award by the Turkish Chemical Society, recognizing his innovative work in metal carbene complexes and boron chemistry. Additionally, Dr. Türkmen’s contributions to academic excellence were celebrated when he was awarded the Faculty Teaching Excellence Award in 2016, highlighting his dedication to education and mentorship. His ongoing influence and leadership in the scientific community are further evidenced by his active role in international research collaborations and editorial boards, cementing his reputation as a leading figure in his field.

Conclusion

Prof. Dr. Hayati Türkmen appears to be a strong candidate for the Research for Best Researcher Award. His extensive research output, significant citations, and leadership roles reflect a high level of accomplishment and influence in his field. Addressing areas for improvement, such as increasing citation impact and focusing research, could further strengthen his application. Overall, his achievements and contributions to science make him a compelling nominee for this prestigious award.

Publications Top Notes

  1. Efficient Synthesis of Novel 1,10 Phenanthroline-Substituted Imidazolium Salts: Exploring Their Anticancer Applications
    • Authors: Çakır, S., Ilhan, S., Atmaca, H., Türkmen, H.
    • Year: 2024
  2. Comparison of Ru(II)‒Arene Complexes Containing Naphthyl-/Quinolinyl-Substituted Ligand Vis-a-Vis Structure, Spectra and Catalytic Activity
    • Authors: Türkmen, G., Çakır, S., Batıkan Kavukcu, S., Şahin, O., Türkmen, H.
    • Year: 2024
    • Citations: 1
  3. Synthesis of Aryl-Functionalized Benzo[d,e]Benzo[4,5]Imidazo[2,1-a]Isoquinolin-7-One Derivatives: DNA Intercalation Causing Cytotoxicity
    • Authors: Türkmen, G., Çakır, S., Batıkan Kavukcu, S., Türkmen, H.
    • Year: 2024
  4. Synthesis and Characterization of Piano-Stool Ruthenium(II)-Arene Complexes of Isatin Schiff Bases: Cytotoxicity and DNA Intercalation
    • Authors: Karabıyık, H., Karaer Tunçay, A., Ilhan, S., Atmaca, H., Türkmen, H.
    • Year: 2024
  5. Ruthenium Compounds: Are They the Next-Era Anticancer Agents?
    • Authors: Kavukcu, S.B., Özverel, C.S., Kıyak, N., Vatansever, H.S., Türkmen, H.
    • Year: 2024
  6. Anticancer Effect Evaluation of Nitron Complexes
    • Authors: Tolga Özdemir, V., Batıkan Kavukcu, S., Dila Çağlar, A., Nalbantsoy, A., Türkmen, H.
    • Year: 2024
  7. Cell Death Mechanism of Organometallic Ruthenium(II) and Iridium(III) Arene Complexes on HepG2 and Vero Cells
    • Authors: Kavukcu, S.B., Ensarioğlu, H.K., Karabıyık, H., Vatansever, H.S., Türkmen, H.
    • Year: 2023
    • Citations: 3
  8. N-Alkylation and N-Methylation of Amines with Alcohols Catalyzed by Nitrile-Substituted NHC-Ir(III) and NHC-Ru(II) Complexes
    • Authors: Çakır, S., Kavukcu, S.B., Şahin, O., Günnaz, S., Türkmen, H.
    • Year: 2023
    • Citations: 11
  9. Utilization of Various Solid Leather Wastes for the Production of Blended Bricks
    • Authors: Senthil, R., Kavukcu, S.B., Çakır, S., Başaran, B., Alagumuthu, T.
    • Year: 2022
    • Citations: 10
  10. Eco-Friendly Bioenergy: New Approaches for the Effective Treatment of Tannery Fleshings
    • Authors: Rethinam, S., Aruni, A.W., Türkmen, H.
    • Year: 2021
    • Citations: 3

 

Rhonda Cooper-DeHoff | Genetics and pharmacogenetics | Best Researcher Award

Posted on by ScienceFather

Dr. Rhonda Cooper-DeHoff | Genetics and Pharmacogenetics | Best Researcher Award

Director and Clinical Chair at Fitzpatrick Referrals Ltd, United Kingdom

Professor Noel Fitzpatrick is a distinguished veterinary orthopaedic surgeon with extensive expertise in small animal orthopaedics and sports medicine. Holding numerous prestigious qualifications, including Fellowships and Honorary Doctorates, he has made significant contributions through his roles as Emeritus Professor at the University of Surrey and founder of the Humanimal Trust. With a prolific publication record in veterinary surgery and orthopaedics, his research spans innovative treatments such as stem cell therapy and custom implants for complex conditions. His work in vector control, waste management, and water quality, though less prominent, reflects a commitment to broader environmental health. Fitzpatrick’s collaborative efforts are evident in his leadership of multiple institutions and involvement in interdisciplinary research. Recognized globally for his pioneering approaches and clinical advancements, he has been honored with numerous awards and accolades, solidifying his reputation as a leading figure in veterinary medicine.

Education

Dr. Rhonda M. Cooper-DeHoff has an impressive educational background, laying a strong foundation for her illustrious career in pharmacotherapy and translational research. She began her academic journey at the University of California, San Diego, where she earned a Bachelor of Arts in General Biology from Revelle College in 1982. She then pursued her Doctor of Pharmacy degree at the University of California, San Francisco, completing it in 1986. Dr. Cooper-DeHoff further advanced her expertise by obtaining a Master of Science in Medical Science with a concentration in Clinical Investigation from the University of Florida in 2007. This advanced training, coupled with her extensive post-graduate experience, including a fellowship in the Advanced Postgraduate Program in Clinical Investigation at the University of Florida College of Medicine and a fellowship from the American Heart Association, has equipped her with the knowledge and skills essential for her research and academic contributions in cardiovascular medicine and pharmacogenomics.

Professional Experience

Dr. Rhonda M. Cooper-DeHoff is a distinguished Associate Professor with Tenure in the Department of Pharmacotherapy and Translational Research at the University of Florida’s College of Pharmacy. Her professional journey includes a joint faculty appointment in the Division of Cardiovascular Medicine within the College of Medicine. Dr. Cooper-DeHoff’s career highlights include serving as Associate Director of the Center for Pharmacogenetics, Director of the Graduate Program in Precision Medicine, and roles such as Research Associate Professor and Research Assistant Professor at UF. Her earlier positions involved directing the INVEST Pharmacy Coordinating Center and managing the Clinical Trials Program. Dr. Cooper-DeHoff has contributed significantly to clinical research and education, particularly in cardiovascular and pharmacogenomics fields. Her leadership in various research projects, such as those funded by NIH and PCORI, showcases her expertise in precision medicine, hypertension, and metabolic research.

Research Interests

Dr. Rhonda M. Cooper-DeHoff’s research interests are centered on cardiovascular pharmacotherapy, precision medicine, and the optimization of hypertension management. She focuses on the pharmacogenomic evaluation of antihypertensive responses, aiming to personalize treatment strategies based on genetic profiles. Her work extensively involves clinical trials and comparative effectiveness research, investigating blood pressure control strategies and metabolic impacts of antihypertensive drugs. Dr. Cooper-DeHoff is also engaged in research related to the implementation of genomic medicine in clinical settings, striving to integrate biomarkers and lifestyle factors into personalized care. Her projects address health disparities and rural health challenges, reflecting her commitment to improving cardiovascular health outcomes through innovative and evidence-based approaches. Through her research, Dr. Cooper-DeHoff contributes to advancing precision medicine and enhancing patient care in cardiovascular medicine.

Research Skills

Dr. Rhonda M. Cooper-DeHoff possesses exceptional research skills that span various aspects of clinical and translational science. Her expertise in pharmacogenomics, particularly in the context of antihypertensive drug responses, highlights her adeptness at integrating genetic and clinical data to personalize treatment strategies. Dr. Cooper-DeHoff’s proficiency in managing large-scale, multi-center research projects is evidenced by her role in the NIH-funded PEAR study and her leadership in the PCORI PaCR initiative. Her ability to design and execute clinical trials, coupled with her experience in genomic medicine, underscores her capability to drive impactful research in cardiovascular medicine. Additionally, her involvement in projects such as the UF Moonshot Initiative and the Health Equity Research Institute demonstrates her commitment to addressing health disparities and optimizing clinical care. Dr. Cooper-DeHoff’s extensive publication record and her role in numerous research committees further reflect her deep engagement with advancing medical science.

Awards and Recognition

Dr. Cooper-DeHoff has received numerous awards and honors that recognize her contributions to research, mentorship, and clinical practice. Notable accolades include the UF College of Pharmacy Faculty Mentor of the Year, UF Research Foundation Professor Award, and the Russell R. Miller Award from the American College of Clinical Pharmacy. These awards reflect her excellence and leadership in the field.

Conclusion

Dr. Rhonda M. Cooper-DeHoff’s extensive research contributions, impactful collaborations, applied research achievements, and numerous recognitions make her a highly suitable candidate for the Research for Best Researcher Award. Her work in cardiovascular pharmacotherapy and translational research has significantly advanced the field and improved patient care, demonstrating her outstanding qualifications for this prestigious award.

Publications Top Notes

  1. Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic
    • Authors: Cicali, E.J., Eddy, E., Gong, Y., George, T.J., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(7)
    • Article: e13890
    • Year: 2024
  2. Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers
    • Authors: Mehanna, M., McDonough, C.W., Smith, S.M., Johnson, J.A., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(5)
    • Article: e13816
    • Year: 2024
  3. Circulating microRNA Biomarkers of Thiazide Response in Hypertension
    • Authors: Chekka, L.M.S., Tantawy, M., Langaee, T., Cooper-Dehoff, R.M., Johnson, J.A.
    • Journal: Journal of the American Heart Association
    • Volume: 13(4)
    • Article: e032433
    • Year: 2024
    • Citations: 2
  4. Initial Antihypertensive Prescribing in Relation to Blood Pressure among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium
    • Authors: Smith, K.M., Keshwani, S., Walsh, M.G., Cooper-Dehoff, R.M., Smith, S.M.
    • Journal: Hypertension
    • Volume: 81(2)
    • Pages: E7-E9
    • Year: 2024
  5. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data
    • Authors: Jafari, E., Cooper-DeHoff, R.M., Effron, M.B., Hogan, W.R., McDonough, C.W.
    • Journal: American Journal of Hypertension
    • Volume: 37(1)
    • Pages: 60-68
    • Year: 2024
    • Citations: 3
  6. In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive Patients
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(6)
    • Pages: 949
    • Year: 2023
  7. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
    • Authors: Joseph, J., Pajewski, N.M., Dolor, R.J., Shivaswamy, V., Ramalingam, R.
    • Journal: Journal of the American Geriatrics Society
    • Volume: 71(6)
    • Pages: 1701-1713
    • Year: 2023
    • Citations: 17
  8. New Drugs Approved in 2022
    • Authors: Ebied, A.M., Elmariah, H., Cooper-DeHoff, R.M.
    • Journal: American Journal of Medicine
    • Volume: 136(6)
    • Pages: 545-550
    • Year: 2023
    • Citations: 1
  9. Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy
    • Authors: Deremer, D.L., Nguyen, N.K., Guha, A., Fradley, M.G., Gong, Y.
    • Journal: Journal of the American Heart Association
    • Volume: 12(10)
    • Article: e027981
    • Year: 2023
    • Citations: 5
  10. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Fontil, V., Knowlton, K.U., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(5)
    • Pages: 662-675
    • Year: 2023
    • Citations: 7